Actym Appoints Steven Vicik as Chief Technical Officer

BERKELEY, CA — October 26, 2023 Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Steven Vicik, PhD, as Chief Technical Officer (CTO). Dr. Steven Vicik joins the company with over 25 years of experience in pharmaceutical process and product development, manufacturing operations, as well as supply chain […]

Article Date

This article is featured on another website.

Go to article